Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03177473 · ClinicalTrials.gov registry record
Study Using the CervicalStim Device Following Cervical Fusion
A clinical trial, sponsored by Orthofix.
- Completed
- Registry status
- 211
- Enrollment target
NCT03177473 is a clinical trial that has completed, run by Orthofix. The registered enrollment target is 211 participants.
The verdict
NCT03177473 has completed, sponsored by Orthofix.
- COMPLETED
- Registry status
- 211 participants
- Enrollment target
Study Summary
This study examines the effect of adjunctive use of the CervicalStim bone growth stimulator on cervical fusion rate in high risk subjects who have undergone cervical fusion surgery. All participants will wear the bone growth stimulator every day for 4 hours/day for 6 months.
Interventions
- DEVICE CervicalStim bone growth stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2017-06-28 |
| Est. Completion | 2021-08-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03177473
The ClinicalTrials.gov registry entry for NCT03177473 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Orthofix, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CervicalStim bone growth stimulator is the first listed.
NCT03177473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03177473 about?
NCT03177473 is a clinical study titled "Study Using the CervicalStim Device Following Cervical Fusion". This study examines the effect of adjunctive use of the CervicalStim bone growth stimulator on cervical fusion rate in high risk subjects who have undergone cervical fusion surgery. All participants will wear the bone growth stimulator every day for 4 hours/day for 6 months.
What is the current status of trial NCT03177473?
This trial is currently completed. The enrollment target is 211 participants. The study started on 2017-06-28. Estimated completion is 2021-08-03.
What interventions are being tested in trial NCT03177473?
The interventions under investigation include: CervicalStim bone growth stimulator (DEVICE).
Who is sponsoring clinical trial NCT03177473?
This trial is sponsored by Orthofix, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.